# Mesenchymal Stem Cell Therapy for Liver Cirrhosis

> **NCT03626090** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Stem Med Pte. Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **BIOLOGICAL:** Autologous BM MSC

## Key facts

- **NCT ID:** NCT03626090
- **Lead sponsor:** Stem Med Pte. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-18
- **Primary completion:** 2021-10-22
- **Final completion:** 2021-10-22
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-03-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03626090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03626090, "Mesenchymal Stem Cell Therapy for Liver Cirrhosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03626090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*